Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Drinking, Acetate, and Stress

Yale University · with National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT06584448

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–60 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
50
US sites recruiting
1
Study start
November 6, 2024
Record last updated
August 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results will lead us to find more effective ways to help people stop or reduce drinking when participants are drinking at harmful levels.

Being studied: Deuterium Metabolic Imaging with deuterated acetate tracer

Conditions: Alcohol Use Disorder; Alcohol Use, Unspecified; Heavy Drinker; Alcohol Use Disorder, Moderate, in Sustained Remission

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Medically stable male or female, aged 18-55.
  • Able to read, write and complete a multitude of self-assessments in English
  • Meets DSM-5 criteria for current Alcohol Use Disorder (AUD)
  • Participants who have Alcohol Use Disorder and are actively drinking must be willing to receive (at no cost) inpatient treatment for AUD for a period of up to 30 days. Participants who have been treated for an Alcohol Use Disorder and are now sober three months or longer will NOT be required to go inpatient.

Exclusion Criteria

  • Subjects with any significant current medical conditions (neurological, cardiovascular, endocrine, thyroid, renal, liver), seizures (for LTS subjects only- seizures directly related to alcohol detoxification are not an exclusion) , delirium or hallucinations, or other unstable medical conditions, including HIV.
  • Current DSM-5 substance use disorder (other than AUD or tobacco use disorder)
  • Any metallic objects implanted in their body which would make imaging unsafe (pacemaker, etc)
  • Claustrophobia, or other inability to participate in an MRI
  • A positive test result at intake appointment and subsequent appointments on urine drug screens conducted for illicit drugs. (Note: participants will not be paid for study visits if they test positive for an illicit drug and will be immediately excluded from study).
  • Women who are pregnant or nursing. Women who have an IUD that would make imaging unsafe.
  • Recent taking of medications that may influence study outcomes (e.g., disulfiram, naltrexone, acamprosate, anticonvulsants).
  • Subjects likely to exhibit clinically significant alcohol withdrawal during the study.

Recruiting US locations

  • The Anlyan Center, 300 Cedar St.

    New Haven, CT 06519

    Site contact: Elizabeth Guidone, BA · 475-375-6141 · Elizabeth.Guidone@yale.edu

Study contacts (from the official record)

  • Graeme Mason, Ph.D. · 203-737-1478 · graeme.mason@yale.edu
  • Luz Catarineau · 475-375-6141 · luz.catarineau@yale.edu
All healthy volunteers studies in Connecticut →
Drinking, Acetate, and Stress (NCT06584448) | Bored Studies